SCHEMBL3454133

SCHEMBL3454133

COC(=O)C1(C(=O)O)C=CC=C(c2ccccc2)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
SLC6A3 Q01959 3/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
CHRM2 P08172 2/20 0.33
CHRM4 P08173 2/20 0.33
CHRM5 P08912 2/20 0.33
CHRM1 P11229 2/20 0.33
CHRM3 P20309 2/20 0.33
HTT P42858 1/20 0.33
TACR1 P25103 1/20 0.33
TACR3 P29371 1/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C19 P33261 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TSHR P16473 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28737053 0.94 MEN1 (0.39) MEN1KMT2ASLC6A3SLC6A2SLC6A4
SCHEMBL4619747 0.86 HDAC4 (0.33) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL28831986 0.83 L3MBTL1 (0.38) CYP1A2SMN1; SMN2NPC1RAB9AL3MBTL1
SCHEMBL19744662 0.81 MEN1 (0.41) MEN1KMT2ASLC6A3SLC6A2SLC6A4
SCHEMBL28852266 0.81 HDAC4 (0.31) NPC1RAB9AHDAC4
SCHEMBL28554255 0.80 MEN1 (0.40) MEN1KMT2ASLC6A3SLC6A2SLC6A4
SCHEMBL28695093 0.80 MEN1 (0.37) MEN1KMT2ASLC6A3SLC6A2SLC6A4
SCHEMBL28737051 0.79 OPRM1 (0.41) MEN1KMT2ASLC6A4CYP1A2CYP2C19
SCHEMBL28981671 0.77 HDAC4 (0.32) MEN1KMT2ANPC1RAB9AALDH1A1
SCHEMBL5581649 0.77 SLC6A3 (0.35) MEN1KMT2ASLC6A3SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1938323-A Silinane compounds as cysteine protease inhibitors SCHERING AG (DE) 2007-03-28 CN claimed
CN-101808990-B Piperidine derivatives as modulators of chemokine receptor activity BRISTOL MYERS SQUIBB CO 2012-09-05 CN disclosed
CN-101808990-A Piperidine derivatives as modulators of chemokine receptor activity BRISTOL MYERS SQUIBB CO 2010-08-18 CN disclosed
EP-2205070-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2010-07-14 EP disclosed
EP-2173714-A1 PIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Company (US) 2010-04-14 EP disclosed
WO-2009045385-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS MERCK & CO., INC. (US) 2009-04-09 WO disclosed
WO-2009015166-A1 PIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-29 WO disclosed
CN-1938323-A Silinane compounds as cysteine protease inhibitors SCHERING AG (DE) 2007-03-28 CN disclosed
EP-1716158-A2 SILINANE COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS Schering Aktiengesellschaft (DE) 2006-11-02 EP disclosed
WO-2005074904-A2 SILINANE COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2005-08-18 WO disclosed